Mirabegron

Anter

• Ma mua o ka lawe ʻana i ka mirabegron,
• Hoʻokumu paha ʻo Mirabegron i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.
• Hiki i nā ʻōuli o ka overdose ke hoʻopili i kēia mau mea:

Hoʻohana wale ʻia ʻo Mirabegron a i ʻole hui pū ʻia me solifenacin (Vesicare) e mālama ai i ka bladder overactive (kahi kūlana kahi e kuʻikahi ai nā mākala o ka pūpū a hana pinepine i ka urination, pono i ka mimiki, a me ka hiki ʻole ke kaohi i ka urination). Aia ʻo Mirabegron i kahi papa o nā lāʻau i kapa ʻia ʻo beta-3 adrenergic agonists. Hana ia e ka hoʻomaha ʻana i nā mākala o ka maʻi huki e pale aku ai i ka urination wikiwiki, pinepine, a i ʻole kaohi ʻole ʻia.

Hele mai ʻo Mirabegron ma ke ʻano he papa hoʻolōʻihi (hana lōʻihi) e lawe ma ka waha. Lawe pinepine ʻia me ka ʻai ʻole a ʻai ʻole hoʻokahi manawa i ka lā. Lawe i ka mirabegron ma kahi o ka manawa like i kēlā me kēia lā. E hāhai pono i nā ʻōkuhi i kāu lepili kuhikuhi, a nīnau i kāu kauka a kauka paha e wehewehe i kahi ʻāpana āu i maopopo ʻole ai. E lawe pololei i ka mirabegron. Mai lawe i ka mea ʻoi aku a liʻiliʻi paha o ia mea a lawe pinepine iā ia ma mua o ka mea i kauoha ʻia e kāu kauka.

E ale i nā papa hoʻolōʻihi-hoʻokuʻu a pau me ka wai; mai hoʻokaʻawale, a nau aku, a hoka ʻole iā lākou.

Hiki i kāu kauka ke hoʻonui i kāu lāʻau, e like me ke ʻano o ka mālama ʻia ʻana o kāu mau ʻōuli a me nā hopena ʻaoʻao āu e ʻike ai. E kamaʻilio me kāu kauka e pili ana i kou ʻano i kou mālama ʻana me ka mirabegron.

Mālama ʻo Mirabegron i nā ʻōuli o ka bladder overactive akā ʻaʻole ia e hoʻōla i ke ʻano. He 8 mau pule paha ka lōʻihi a ʻoi paha ma mua o kou ʻike ʻana i ka pono piha o ka mirabegron. E hoʻomau i ka lawe mirabegron ʻoiai ʻoe e manaʻo maikaʻi. Mai hōʻoki i ka lawe ʻana i ka mirabegron me ke kamaʻilio ʻole ʻana me kāu kauka.

E noi i kāu kauka lāʻau a kauka paha no kahi kope o ka ʻike a ka mea hana no ka mea maʻi.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka lawe ʻana i ka mirabegron,

• e haʻi i kāu kauka a me kāu kauka lāʻau inā he maʻi ʻoe i ka mirabegron, nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i loko o ka papa ʻoi loa-hoʻokuʻu hoʻokuʻu ʻia ʻo mirabegron. E noi i kāu kauka lāʻau a nānā i ka ʻike hoʻomanawanui no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau he aha nā lāʻau lapaʻau a me nā lāʻau ʻole i kuhikuhi ʻia, nā wikamina, nā mea hoʻopihaʻai, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe E hōʻoia e haʻi i kekahi o kēia mau mea: anticoagulants ('nā mea lahilahi o ke koko) e like me warfarin (Coumadin, Jantoven); desipramine (Norpramin); digoxin (Lanoxin); flecainide (Tambocor); nā lāʻau lapaʻau ʻē aʻe no ka bladder overactive e like me darifenacin (Enablex), fesoterodine (Toviaz), oxybutynin (Glenique, Oxytrol), solifenacin (VESIcare), tolterodine (Detrol), a me trospium; propafenone (Rhythmol); metoprolol (Lopressor, Toprol, ma Dutoprol); a me thioridazine. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao.
• e haʻi i kāu kauka inā loaʻa iā ʻoe a i ʻole loaʻa i ka pale o ka puka bladder (kahi paʻa ma ke kumu o ka hakahaka e hoʻōki ana i ka mimi mai ka kahe manuahi ʻana mai ka pākeke a hana i ka paʻakikī i ka hoʻolei ʻana i ka ʻai a me / a i ʻole kahi kahawai nawaliwali nāwaliwali), ke koko kiʻekiʻe. , a i ʻole ka maʻi ʻaʻai a i ʻole ate.

• E haʻi i kāu kauka inā hāpai ʻoe, e hoʻolālā e hāpai, a i ʻole e hānai umauma ana. Inā hāpai ʻoe i ka lawe ʻana i ka mirabegron, e kāhea i kāu kauka.

  
  
• pono ʻoe e ʻike e hoʻonui paha kou kahe koko i kou wā e mālama ai me ka mirabegron. E nānā pinepine kāu kauka i kou kaomi koko i kou wā e lapaʻau ai.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

E haʻalele i ka lāʻau i haʻalele ʻia a hoʻomau i kāu papa hana maʻamau. Mai lawe i hoʻokahi ma mua o hoʻokahi mahele lāʻau i ka lā hoʻokahi a mai lawe i kahi lāʻau pālua e pani no kahi mea i hala.

Hoʻokumu paha ʻo Mirabegron i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• ʻeha poʻo
• ʻūpā
• waha maloo
• kōpaʻa
• ʻeha kua
• ʻeha pū
• ka pilikia i ka ninini ʻana i ka puhā, a i ʻole ka wai mimi nāwaliwali (ʻoi aku ke hoʻohana ʻia me solifenacin)

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e kāhea koke i kāu kauka a i ʻole e kiʻi i ka lāʻau olakino olakino.

• pehu o ka maka, lehelehe, alelo a puʻu paha, paʻakikī i ka hanu ʻana a me ka ale ʻana paha, ka hives, ka pehu, ka ʻili
• paʻakikī, ʻeha, ʻūlū, a i ʻole ka urino pinepine

Hoʻokumu paha ʻo Mirabegron i nā hopena ʻē aʻe. Kāhea i kāu kauka inā he pilikia ʻokoʻa kāu i ka lawe ʻana i kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E mālama i kēia lāʻau i loko o ka pahu i komo ai, pani paʻa ʻia, a ʻaʻole hiki i nā kamaliʻi. E mālama iā ia i ka mahana wela o ka lumi a ma kahi o ka wela a me ka momona (ʻaʻole i ka lua.

Pono e hoʻolei ʻia nā lāʻau i koi ʻole ʻia i nā ala kūikawā e hōʻoia i ka hiki ʻole i nā holoholona, ​​nā keiki, a me nā poʻe ʻē aʻe ke hoʻopau iā lākou. Eia nō naʻe, ʻaʻole pono ʻoe e kaomi i kēia lāʻau i ka lua. Akā, ʻo ke ala ʻoi loa e hoʻolilo i kāu lāʻau i loko o kahi papahana hoʻihoʻi lāʻau. E kamaʻilio me kāu kauka lāʻau a kāhea paha i kāu ʻōpala a me nā hana hoʻopōʻaiapuni kūloko e aʻo e pili ana i nā papahana hoʻihoʻi i kou kaiāulu. E ʻike i ka pūnaewele palekana o kā FDA's Disposal of Medicines (http://goo.gl/c4Rm4p) no ka ʻike hou aku inā ʻaʻohe ou komo i kahi papahana hoʻihoʻi.

He mea nui e mālama i nā lāʻau āpau mai ka maka a hiki i nā keiki e like me nā ipu (e like me nā minder pill i kēlā me kēia pule a me nā mea no nā kulu maka, nā kalima, nā pākuʻi, a me nā inhalers) ʻaʻole pale keiki a hiki i nā keiki ʻōpio ke wehe maʻalahi iā lākou. No ka pale ʻana i nā keiki ʻōpio mai ka lāʻau make, laka mau i nā pāpale palekana a kau koke i ka lāʻau i kahi palekana - kahi i luna a mamao a mai ko lākou alo a hiki. http://www.upandaway.org

I ke kumu o ka overdose, e kāhea i ka helpline kaohi lāʻau make ma 1-800-222-1222. Loaʻa ka ʻike ma ka pūnaewele ma https://www.poisonhelp.org/help. Inā ua hina ka mea i hoʻomāinoino ʻia, loaʻa ka hopu ʻana, pilikia i ka hanu ʻana, a i ʻole hiki ʻole ke ala aʻe, e kāhea koke i nā lawelawe kūikawā ma 911.

Hiki i nā ʻōuli o ka overdose ke hoʻopili i kēia mau mea:

• wikiwiki a kuʻi paha i ka puʻuwai puʻuwai

Mālama i nā manawa āpau me kāu kauka.

Mai ʻae i kahi mea ʻē aʻe e lawe i kāu lāʻau. E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka hoʻopiha hou ʻana i kāu kuhikuhi.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• ʻO Myrbetriq^®